Annual Total Expenses
$163.77 M
+$31.60 M+23.90%
December 1, 2024
Summary
- As of March 12, 2025, TRDA annual total expenses is $163.77 million, with the most recent change of +$31.60 million (+23.90%) on December 1, 2024.
- During the last 3 years, TRDA annual total expenses has risen by +$112.64 million (+220.32%).
- TRDA annual total expenses is now at all-time high.
Performance
TRDA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$43.27 M
+$2.04 M+4.94%
December 1, 2024
Summary
- As of March 12, 2025, TRDA quarterly total expenses is $43.27 million, with the most recent change of +$2.04 million (+4.94%) on December 1, 2024.
- Over the past year, TRDA quarterly total expenses has stayed the same.
- TRDA quarterly total expenses is now at all-time high.
Performance
TRDA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TRDA Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.9% | 0.0% |
| 3 y3 years | +220.3% | +69.1% |
| 5 y5 years | +1285.1% | +69.1% |
TRDA Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +220.3% | at high | +134.4% |
| 5 y | 5-year | at high | +1285.1% | at high | +520.5% |
| alltime | all time | at high | +1285.1% | at high | +520.5% |
Entrada Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $163.77 M(+23.9%) | $43.27 M(+4.9%) |
| Sep 2024 | - | $41.23 M(-0.1%) |
| Jun 2024 | - | $41.27 M(+8.6%) |
| Mar 2024 | - | $38.01 M(+2.9%) |
| Dec 2023 | $132.18 M(+35.9%) | $36.94 M(+24.3%) |
| Sep 2023 | - | $29.72 M(-13.8%) |
| Jun 2023 | - | $34.47 M(+11.0%) |
| Mar 2023 | - | $31.04 M(+21.3%) |
| Dec 2022 | $97.25 M | $25.58 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $25.94 M(+10.0%) |
| Jun 2022 | - | $23.58 M(+6.5%) |
| Mar 2022 | - | $22.15 M(+20.0%) |
| Dec 2021 | $51.13 M(+91.7%) | $18.46 M(+28.5%) |
| Sep 2021 | - | $14.36 M(+44.9%) |
| Jun 2021 | - | $9.91 M(+18.1%) |
| Mar 2021 | - | $8.39 M(-3.0%) |
| Dec 2020 | $26.67 M(+125.5%) | $8.65 M(+24.1%) |
| Sep 2020 | - | $6.97 M |
| Dec 2019 | $11.82 M | - |
FAQ
- What is Entrada Therapeutics annual total expenses?
- What is the all time high annual total expenses for Entrada Therapeutics?
- What is Entrada Therapeutics annual total expenses year-on-year change?
- What is Entrada Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly total expenses year-on-year change?
What is Entrada Therapeutics annual total expenses?
The current annual total expenses of TRDA is $163.77 M
What is the all time high annual total expenses for Entrada Therapeutics?
Entrada Therapeutics all-time high annual total expenses is $163.77 M
What is Entrada Therapeutics annual total expenses year-on-year change?
Over the past year, TRDA annual total expenses has changed by +$31.60 M (+23.90%)
What is Entrada Therapeutics quarterly total expenses?
The current quarterly total expenses of TRDA is $43.27 M
What is the all time high quarterly total expenses for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly total expenses is $43.27 M
What is Entrada Therapeutics quarterly total expenses year-on-year change?
Over the past year, TRDA quarterly total expenses has changed by $0.00 (0.00%)